pentosidine has been researched along with Diabetic Angiopathies in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (35.71) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barzilay, JI; Fonseca, V; Goldfine, AB; Jablonski, KA; Monnier, VM; Shoelson, SE; Strauch, C | 1 |
Borsos, AM; M'bemba, J; Peyroux, J; Selam, JL; Slama, G; Sternberg, M; Urios, P | 1 |
Dagnelie, PC; Henry, RM; Koster, A; Kroon, AA; Schalkwijk, CG; Schaper, N; Scheijen, J; Schram, MT; Sep, SJ; Smit, AJ; Stehouwer, CD; van der Kallen, CJ; van Eupen, MG; van Sloten, TT | 1 |
Ben Yahya, S; Bouzidi, H; Hammami, M; Kerkeni, M; Saïdi, A | 1 |
Furfaro, AL; Monacelli, F; Odetti, P; Pronzato, MA; Puzzo, A; Sanguineti, R; Storace, D; Traverso, N | 1 |
Ben Yahia, S; Bouzidi, H; Hammami, M; Kerkeni, M; Letaief, A; Saïdi, A | 1 |
Hirata, K; Kubo, K | 1 |
Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; McCance, DR; Thorpe, SR | 1 |
Bailey, AJ; Oxlund, H; Rasmussen, LM; Sims, TJ | 1 |
Donker, AJ; Schalkwijk, CG; Smulders, RA; Stehouwer, CD; TeKoppele, JM; van Hinsbergh, VW | 1 |
Kawashima, S; Kurokawa, K; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Ueda, Y; Van Ypersele de Strihou, C | 1 |
Asahi, K; Horie, K; Inagi, R; Kurokawa, K; Miyata, T; Sakai, H; Uchida, K; Yamada, Y | 1 |
Fedele, D; Lapolla, A; Traldi, P | 1 |
Aricó, CN; Bernich, P; Brezzi, B; Lapolla, A; Lupo, A; Maiorca, P; Marcantoni, C; Maschio, G; Rugiu, C | 1 |
2 review(s) available for pentosidine and Diabetic Angiopathies
Article | Year |
---|---|
AGE in micro- and macroangiopathy.
Topics: Aging; Animals; Arginine; Arteriosclerosis; Cell Adhesion; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Interferon-gamma; Lysine; Membrane Proteins; Microcirculation; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; T-Lymphocytes; Vascular Diseases | 2001 |
The dialytic failure of the peritoneal membrane.
Topics: Aquaporin 1; Aquaporins; Arginine; Basement Membrane; Biological Transport; Blood Group Antigens; Body Water; Cross-Sectional Studies; Diabetic Angiopathies; Dialysis Solutions; Drug Packaging; Equipment Design; Female; Fibrosis; Glucose; Glycation End Products, Advanced; Glycosylation; Humans; Longitudinal Studies; Lysine; Male; Membrane Proteins; Molecular Weight; Osmotic Pressure; Oxidation-Reduction; Peritoneal Dialysis; Peritoneum; Peritonitis; Permeability; Sterilization; Time Factors; Treatment Failure | 2001 |
2 trial(s) available for pentosidine and Diabetic Angiopathies
Article | Year |
---|---|
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
Topics: Adiponectin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyruvaldehyde; Salicylates | 2014 |
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Analysis of Variance; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Sensitivity and Specificity; Severity of Illness Index | 1998 |
10 other study(ies) available for pentosidine and Diabetic Angiopathies
Article | Year |
---|---|
Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Biopsy; Case-Control Studies; Collagen; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Female; Fluorescence; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2016 |
Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study.
Topics: Adult; Aged; Analysis of Variance; Arginine; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glucose; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Middle Aged; Optical Imaging; Prospective Studies; Pulse Wave Analysis; Skin; Vascular Stiffness | 2016 |
Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Tunisia | 2012 |
Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Carotid Artery, Internal; Carotid Stenosis; Diabetic Angiopathies; Extracellular Matrix; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Inflammation Mediators; Interleukin-1alpha; Italy; Lysine; Matrix Metalloproteinase 2; Metalloproteases; Plaque, Atherosclerotic; Risk Factors; Severity of Illness Index; Tissue Inhibitor of Metalloproteinase-3 | 2012 |
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Topics: Aged; Arginine; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Hyperlipidemias; Hypertension; Lysine; Male; Microvessels; Middle Aged; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Up-Regulation | 2013 |
Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2004 |
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Maillard Reaction; Male; Microcirculation; Middle Aged; Skin | 1993 |
The role of glycation cross-links in diabetic vascular stiffening.
Topics: Adult; Aged; Aging; Amino Acids; Aorta, Thoracic; Arginine; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Elastin; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; Time Factors | 1996 |
Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; E-Selectin; Endothelium, Vascular; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Linear Models; Logistic Models; Lysine; Male; Middle Aged; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 1998 |
Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids.
Topics: Arachidonic Acid; Arginine; Arteriosclerosis; Ascorbic Acid; Diabetic Angiopathies; Glucose; Glycation End Products, Advanced; Glycosylation; Humans; Lipid Peroxidation; Lipoproteins; Lysine; Malondialdehyde; Oxidation-Reduction; Oxidative Stress | 1998 |